Is WELL a Buy? What to Consider in 2026
Short answer
The bull case for Welltower (WELL) rests on Aging-demographics senior-housing tailwind: Welltower's central thesis is that the 80-plus population is growing rapidly while new senior-housing construction has stayed near multi-decade lows, creating a widening gap between demand and supply. SHOP same-store NOI growth (Q4 2025) is ~20.4% YoY. If you believe that thesis holds, the real questions become position sizing and overlap, not timing. The main risk to that view: Welltower's share price is sensitive to interest rates, since higher rates raise borrowing costs and make REIT dividend yields less competitive against bonds. Whether WELL is a buy comes down to whether you believe the thesis. This is informational, not a recommendation, and Walnut is not an investment adviser.
Welltower Inc. is the largest healthcare REIT in the world, owning a portfolio of senior housing, assisted living, post-acute and long-term care, and outpatient medical real estate across the United States, the United Kingdom, and Canada. It makes money in two main ways: through its Senior Housing Operating Portfolio (SHOP), where it shares directly in the net operating income that property operators generate from residents, and through rents on triple-net leased seniors housing and care facilities plus outpatient medical buildings. Because SHOP income flows through to Welltower rather than being fixed rent, rising occupancy and room rates translate quickly into higher earnings, which is why the operating portfolio has become the company's main growth engine. Welltower traces its roots to 1970 and grew over decades into a diversified healthcare landlord before reshaping its portfolio around senior housing. The senior-housing sector was hit hard during the pandemic as occupancy fell, but it has staged a strong multi-year recovery as demand from an aging population outpaced limited new construction. That recovery accelerated through 2025: full-year normalized FFO reached $5.29 per share, up about 22.5% over 2024, revenue rose roughly 36% to about $10.84 billion, and in the fourth quarter the SHOP same-store portfolio grew net operating income about 20.4% year over year with occupancy near 89.5%. The company completed roughly $11 billion of net investments in 2025, continued to recycle capital out of outpatient medical, and is leaning on its Welltower Business System, an in-house operating and data platform, to push margins higher.
What's the case for buying WELL?
1. Aging-demographics senior-housing tailwind.
Welltower's central thesis is that the 80-plus population is growing rapidly while new senior-housing construction has stayed near multi-decade lows, creating a widening gap between demand and supply. That dynamic supported about 400 basis points of average occupancy growth and 9.6% organic same-store revenue growth in the SHOP portfolio in Q4 2025. Occupancy reached roughly 89.5%, still below historical peaks, leaving room for further gains. Management frames this demand wave as a multi-year, not single-year, opportunity.
2. Operating-portfolio NOI growth.
Because Welltower captures the upside in its SHOP communities directly, occupancy and rate gains flow straight to earnings. SHOP same-store NOI grew about 20.4% year over year in Q4 2025, lifting total portfolio same-store NOI about 15%. For 2026 the company guided to SHO same-store NOI growth of 15% to 21% and total same-store NOI growth of 11.25% to 15.75%, an unusually high range for a REIT. That operating leverage is the main driver of FFO growth.
3. Heavy capital deployment and pipeline.
Welltower deployed roughly $11 billion of pro rata net investments in 2025, concentrated in U.S. and U.K. seniors housing, while executing about $8.2 billion of dispositions including a large outpatient medical portfolio. It reported $10.5 billion of closed or announced investment activity through the first four months of 2026 and described its pipeline as never stronger. A strong balance sheet and access to capital let it keep acquiring at scale, which adds external growth on top of internal NOI gains.
4. Rising FFO and a growing dividend.
Normalized FFO grew about 22.5% to $5.29 per share in 2025, and the company guided to $6.09 to $6.25 for 2026. On the strength of that cash-flow growth and a low payout ratio, the board approved a 15% increase in the quarterly dividend to $0.85 per share (about $3.40 annualized) starting in the second quarter of 2026. The Welltower Business System, its operating and data platform, is positioned to push operating margins further over time.
What are the risks to WELL?
Welltower's share price is sensitive to interest rates, since higher rates raise borrowing costs and make REIT dividend yields less competitive against bonds. The senior-housing operating model also carries labor cost and staffing pressures and depends on occupancy holding up, so a weaker demand environment or wage inflation could compress margins. The stock trades at a premium valuation relative to many healthcare REIT peers, which leaves limited room for disappointment and makes it vulnerable to multiple compression. The company is also deploying capital aggressively, so acquisition execution, integration, and the cost of financing that growth are real risks if returns on new investments fall short.
How is WELL valued? (as of FY2025 results (year ended December 31, 2025) and 2026 guidance)
- Normalized FFO per share (2025): $5.29 (+~22.5%)
- 2026 normalized FFO guidance: $6.09 to $6.25
- SHOP same-store NOI growth (Q4 2025): ~20.4% YoY
- Revenue (2025): ~$10.84 billion (+~36%)
- SHOP occupancy (Q4 2025): ~89.5%
- Dividend (2026): $0.85/qtr (~$3.40/yr), yield ~1.5%
- Market cap: ~$145 billion
Healthcare REITs are valued on funds from operations (FFO) rather than EPS, because standard net income is weighed down by large non-cash depreciation charges on real estate. For Welltower the most important operating metric is same-store NOI growth in the Senior Housing Operating Portfolio, since that captures how much extra income the company earns as occupancy and room rates rise. Welltower trades at a notably higher FFO multiple, and a lower dividend yield, than most healthcare REIT peers, reflecting the market's confidence in its senior-housing growth, its scale, and its balance sheet; that premium is part of the investment case and part of the risk.
How do you decide if WELL is a buy?
Rather than asking whether WELL is a buy in the abstract, it tends to help to answer four questions:
- Thesis: do you believe the case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold WELL indirectly through an index or sector ETF before adding more.
For the full picture, see the WELL stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about WELL against your real portfolio and see your actual exposure before deciding.
The bottom line on WELL
The bottom line: Welltower's story right now is Aging-demographics senior-housing tailwind, with shop same-store noi growth (q4 2025) at ~20.4% YoY. If you believe that narrative continues, the call is about sizing WELL sensibly and checking overlap with what you own; if you doubt it (the risk: welltower's share price is sensitive to interest rates, since higher rates raise borrowing costs and make REIT dividend yields less competitive against bonds.), it is not for you. Decide from the thesis, not the ticker. Walnut is not an investment adviser.
Build a basket around WELL with Walnut
Use Welltower as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
Is WELL a good stock to buy right now?
+
The case for Welltower right now is Aging-demographics senior-housing tailwind, with shop same-store noi growth (q4 2025) at ~20.4% YoY. If you believe that thesis holds, WELL is a way to own it and the real questions are sizing and overlap, not timing; the main risk to that view is welltower's share price is sensitive to interest rates, since higher rates raise borrowing costs and make REIT dividend yields less competitive against bonds. So it comes down to whether you believe the thesis. Walnut is not an investment adviser and this is not a recommendation.
What does Welltower do?
+
The largest healthcare REIT, riding an aging-demographics senior-housing recovery through its operating portfolio, outpatient medical, and triple-net leased care properties.
What are the main risks of WELL?
+
Welltower's share price is sensitive to interest rates, since higher rates raise borrowing costs and make REIT dividend yields less competitive against bonds. The senior-housing operating model also carries labor cost and staffing pressures and depends on occupancy holding up, so a weaker demand environment or wage inflation could compress margins. The stock trades at a premium valuation relative to many healthcare REIT peers, which leaves limited room for disappointment and makes it vulnerable to multiple compression. The company is also deploying capital aggressively, so acquisition execution, integration, and the cost of financing that growth are real risks if returns on new investments fall short.
What does Welltower do?
+
Welltower is the largest healthcare real estate investment trust. It owns senior housing, assisted living, post-acute and long-term care, and outpatient medical properties, mainly in the United States, the United Kingdom, and Canada. It earns money both from rents on leased facilities and, in its Senior Housing Operating Portfolio, by sharing directly in the net operating income that property operators generate.
Does WELL pay a dividend?
+
Yes. Welltower pays a quarterly dividend, and its board approved a 15% increase to $0.85 per share (about $3.40 annualized) starting in the second quarter of 2026. The yield is relatively low for a REIT, around 1.5%, because the stock trades at a premium and the company keeps a low FFO payout ratio so it can reinvest cash flow into growth.
What is a healthcare REIT and what is the senior-housing demographic tailwind?
+
A healthcare REIT is a company that owns income-producing healthcare real estate, such as senior housing and medical buildings, and passes most of its taxable income to shareholders as dividends. The senior-housing demographic tailwind refers to the rapidly growing population of people over 80, combined with low new construction, which has pushed senior-housing occupancy and rents higher and is the core driver of Welltower's recent growth.
Is WELL sensitive to interest rates and valuation?
+
Yes. Like most REITs, Welltower's share price reacts to interest rates, since higher rates raise its borrowing costs and make its dividend yield less attractive versus bonds. It also trades at a premium FFO multiple compared with peers, so the market is pricing in continued strong growth. That premium leaves less margin for error if senior-housing growth slows or rates move against it.
Walnut is informational and is not an investment adviser. This page is educational and not a recommendation to buy or sell WELL; figures are approximate and dated, and your own situation, time horizon, and risk tolerance should drive any decision. Verify current data before investing.